Shares in Danish drug maker Novo Nordisk have increased following President Biden's proposal to expand Medicare and Medicaid coverage for anti-obesity drugs. This change, effective by 2026, could ...

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

Novo Nordisk is encouraged by White House proposals that could support patients using weight-loss drugs, but cautioned that ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The good news is that HHS recognizes that vitally important anti-obesity medicines like Wegovy and Zepbound should be made available to all Americans, regardless of income. The bad news is that unless ...

Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' ...

Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding ...

The Danish Green Tripartite could lock in the existing industrial farming system, based on the promises of questionable ...

While a region’s economic growth seldom maps readily onto stock market growth, there are times when specific areas appear to ...

Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...